Clinical Trials Logo

Clinical Trial Summary

This is an observations study evaluating safety and efficacy of immunoadsorption compared to plasma exchange in Guillain-Barré Syndrome.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04871035
Study type Observational
Source University of Ulm
Contact Johannes Dorst, Prof
Phone +49 731 177 5285
Email johannes.dorst@uni-ulm.de
Status Recruiting
Phase
Start date April 28, 2021
Completion date May 4, 2025

See also
  Status Clinical Trial Phase
Withdrawn NCT04116645 - Time Frame for GBS Screening
Not yet recruiting NCT01833780 - Effectiveness of Intrapartum Group B Streptococcus (GBS) Polimerase Chain Reaction Reaction (PCR) Screening N/A
Completed NCT02497430 - Clinical Evaluation of the ARIES Group B Streptococcus (GBS) Assay N/A
Completed NCT03936816 - The Implementation of Real-time PCR - Intrapartum GBS (Group B Streptococcus) Colonization to Reduce Antibiotic Prophylaxis
Completed NCT03008421 - Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy N/A
Not yet recruiting NCT03064672 - Transcervical Balloon Catheters in GBS Carriers, Is It Safe? A Randomized Controlled Trial N/A
Completed NCT02883270 - Effects of Robotic-assisted Gait Training In Non-Ambulatory Patients After Guillain-Barré Syndrome N/A
Completed NCT04434391 - QF-PCR In GBS Diagnosis During Pregnancy